ginsenoside rh2 has been researched along with 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) | Trials (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) | Recent Studies (post-2010) (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 156 | 1 | 44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Feng, Z; Li, D; Li, J; Luo, L; Shi, Q; Xia, J; You, Z; Zhao, L; Zuo, G | 1 |
1 other study(ies) available for ginsenoside rh2 and 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate
| Article | Year |
|---|---|
Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: recruiting histone deacetylase and inhibiting activator protein 1 transcription factors.
Topics: Cell Movement; Down-Regulation; Ginsenosides; Hep G2 Cells; Histone Deacetylases; Humans; Liver Neoplasms; Matrix Metalloproteinase 3; Repressor Proteins; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2014 |